Current Report Filing (8-k)
07 Februar 2023 - 12:07PM
Edgar (US Regulatory)
0001843724
false
0001843724
2023-02-06
2023-02-06
0001843724
amci:UnitsEachConsistingOfOneShareOfClassCommonStockAndOnehalfOfOneRedeemableWarrantMember
2023-02-06
2023-02-06
0001843724
us-gaap:CommonStockMember
2023-02-06
2023-02-06
0001843724
amci:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockEachAtExercisePriceOf11.50PerShareMember
2023-02-06
2023-02-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
February 6, 2023
AMCI ACQUISITION CORP. II
(Exact name of registrant as specified in its charter)
Delaware |
001-40282 |
86-1763050 |
(State or other jurisdiction
of incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) |
1600 Steamboat Road
Greenwich, Connecticut 06830
(Address of principal executive offices, including
zip code)
Registrant’s telephone number, including
area code: (203) 625-9200
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange
on which registered |
Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant |
|
AMCIU |
|
The Nasdaq Stock Market LLC |
Class A common stock, par value $0.0001 per share |
|
AMCI |
|
The Nasdaq Stock Market LLC |
Redeemable warrants, each warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 |
|
AMCIW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01. |
Entry into a Material Definitive Agreement. |
Subscription Agreements
As previously announced,
on March 8, 2022, AMCI Acquisition Corp. II, a Delaware corporation (the “Company”), entered into an Agreement
and Plan of Merger with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (“Merger Sub”),
and LanzaTech NZ, Inc. (“LanzaTech”), a Delaware corporation (the “Merger Agreement”).
If the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the
conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech,
with LanzaTech surviving the merger as a wholly owned subsidiary of AMCI (the “Merger”). The transactions contemplated
by the Merger Agreement are herein referred to as the “Business Combination.”
On February 6, 2023, the
Company entered into a subscription agreement and on February 4, 2023, the Company entered into an amendment to an existing
subscription agreement (collectively, the “Subscription Agreements”) with certain accredited investors
(collectively, the “Third PIPE Investors”), pursuant to which, among other things, the Company agreed to
issue and sell, in a private placement to close immediately prior to the closing of the Merger, an aggregate of 500,000 shares of
Class A common stock, par value $0.0001 per share, of the Company (the “AMCI Class A Common Stock”) at a
purchase price of $10.00 per share (the “Third PIPE Investment”) to the Third PIPE Investors.
The Third PIPE
Investment represents the parties’ efforts to raise additional capital in order to satisfy the Minimum Closing Cash Condition
(as defined in the Merger Agreement). The Third PIPE Investment is in addition to the 12,500,000 shares of AMCI Class A Common Stock
that AMCI agreed to sell, in a private placement to close immediately prior to the closing of the Merger, to certain other
accredited investors and qualified institutional buyers as reported on a Current Report on Form 8-K filed with the U.S. Securities
and Exchange Commission (the “SEC”) on March 8, 2022 (the “First PIPE
Investment”) and the additional 5,500,000 shares of AMCI Class A Common Stock that AMCI agreed to sell in a second
such private placement as reported on a Current Report on Form 8-K filed with the SEC on October 24, 2022 (the “Second
PIPE Investment” and, together with the First PIPE Investment and the Third PIPE Investment, the “PIPE
Investment”). The accredited investors and qualified institutional buyers in the PIPE Investment, including the Third
PIPE Investors, are collectively referred to herein as the “PIPE Investors.” To date, the PIPE Investors
have agreed to purchase shares of AMCI Class A Common Stock for an aggregate purchase price of $185,000,000 in the PIPE
Investment.
The foregoing description
of the Third PIPE Investment and the Subscription Agreements does not purport to be complete and is qualified in its entirety by the terms
and conditions of the Subscription Agreements, copies of which are filed as Exhibits 10.1 and 10.2 hereto and are incorporated by reference
herein.
Item 3.02 |
Unregistered Sales of Equity Securities. |
The disclosure set forth above
under the caption “Subscription Agreements” in Item 1.01 of this Current Report is incorporated by reference herein. The shares
of AMCI Class A Common Stock issuable in connection with the Third PIPE Investment will not be registered under the Securities Act, in
reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.
Item 5.07 |
Submission of Matters to a Vote of Security Holders. |
On February 6, 2023, the
Company held a special meeting of its stockholders (the “Special Meeting”). At the Special Meeting, a total
of 16,080,509 (or 85.76%) of the Company’s issued and outstanding shares of common stock held of record as of December 28, 2022,
the record date for the Special Meeting, were present either in person or by proxy, which constituted a quorum. The Company’s stockholders
voted on the following proposals at the Special Meeting, each of which was approved. The final vote tabulation for each proposal is set
forth below.
1. |
The Company’s stockholders voted to approve and adopt the Merger Agreement and the Business Combination. The combined company following the closing will be renamed “LanzaTech Global, Inc.” (the “New LanzaTech”). The votes cast were as follows: |
Votes For |
|
Votes Against |
|
Abstentions |
|
15,302,280 |
|
778,029 |
|
200 |
|
2. |
The Company’s stockholders voted to approve the second amended and restated certificate of incorporation of the Company (the “Proposed Charter”), which will replace the Company’s amended and restated certificate of incorporation, dated August 3, 2021 (the “Current Charter”) effective upon the closing of the Business Combination (the “Closing”). The votes cast were as follows: |
Votes For |
|
Votes Against |
|
Abstentions |
|
11,220,974 (Class A Common Stock) |
|
1,109,335 (Class A Common Stock) |
|
200 (Class A Common Stock) |
|
3,750,000 (Class B Common Stock) |
|
0 (Class B Common Stock) |
|
0 (Class B Common Stock) |
|
3. | The Company’s stockholders voted to approve the reclassification of the Company’s Class A Common Stock and the Company’s
Class B common stock, par value $0.0001 per share (“AMCI Class B Common Stock”) into a single class of common
stock, par value $0.0001 per share, of New LanzaTech (“New LanzaTech Common Stock”). The
votes cast were as follows: |
Votes For |
|
Votes Against |
|
Abstentions |
|
11,552,276 (Class A Common Stock) |
|
778,029 (Class A Common Stock) |
|
204 (Class A Common Stock) |
|
3,750,000 (Class B Common Stock) |
|
0 (Class B Common Stock) |
|
0 (Class B Common Stock) |
|
4. | The Company’s stockholders voted to approve the
increase in the number of authorized shares of New LanzaTech Common Stock from 300,000,000
shares to 400,000,000 shares and the increase in the number of authorized shares of preferred
stock of New LanzaTech, par value $0.0001 per share (“New LanzaTech Preferred
Stock”), from 1,000,000 shares to 20,000,000 shares. The
votes cast were as follows: |
Votes For |
|
Votes Against |
|
Abstentions |
|
11,551,751 (Class A Common Stock) |
|
778,239 (Class A Common Stock) |
|
519 (Class A Common Stock) |
|
3,750,000 (Class B Common Stock) |
|
0 (Class B Common Stock) |
|
0 (Class B Common Stock) |
|
| 5. | The Company’s stockholders voted to approve, on a non-binding
advisory basis, the following differences between the Proposed Charter and the Current Charter, which were presented separately, in accordance
with the requirements of the U.S. Securities and Exchange Commission, as five sub-proposals: |
a. |
To provide that New LanzaTech will have authorized capital stock of 420,000,000 shares, consisting of 400,000,000 shares of New LanzaTech Common Stock and 20,000,000 shares of New LanzaTech Preferred Stock, as opposed to the Company having authorized capital stock of 301,000,000 shares, consisting of 280,000,000 shares of AMCI Class A Common Stock, 20,000,000 shares of AMCI Class B Common Stock and 1,000,000 shares of preferred stock of the Company. The votes cast were as follows: |
Votes For |
|
Votes Against |
|
Abstentions |
|
14,403,067 |
|
1,676,733 |
|
709 |
|
b. |
To provide that directors of New LanzaTech may be removed from office only for cause and only with the affirmative vote of the holders of at least 66 2/3% of the voting power of the outstanding shares of stock of New LanzaTech. The votes cast were as follows: |
Votes For |
|
Votes Against |
|
Abstentions |
|
14,055,458 |
|
2,014,249 |
|
10,802 |
|
c. |
To change the stockholder vote required to amend certain provisions of the Proposed Charter. The votes cast were as follows: |
Votes For |
|
Votes Against |
|
Abstentions |
|
13,305,434 |
|
2,764,086 |
|
10,989 |
|
d. |
To prohibit all stockholders from acting by written consent by specifying that any action required or permitted to be taken by stockholders must be effected by a duly called annual or special meeting and may not be effected by written consent. The votes cast were as follows: |
Votes For |
|
Votes Against |
|
Abstentions |
|
14,057,630 |
|
2,022,369 |
|
510 |
|
e. |
To provide for certain additional changes, including, among other things, (i) changing New LanzaTech’s corporate name from “AMCI Acquisition Corp. II” to “LanzaTech Global, Inc.” and making New LanzaTech’s corporate existence perpetual and (ii) removing certain provisions related to the Company’s status as a blank check company that will no longer apply upon Closing. The votes cast were as follows: |
Votes For |
|
Votes Against |
|
Abstentions |
|
15,301,976 |
|
778,029 |
|
504 |
|
6. |
The Company’s stockholders voted to approve, for the purposes of complying with the applicable listing rules of The Nasdaq Stock Market LLC, the issuance of (x) shares of New LanzaTech Common Stock pursuant to the terms of the Merger Agreement and (y) shares of AMCI Class A Common Stock to the PIPE Investors in connection with the PIPE Investment, plus any additional shares pursuant to subscription agreements or other agreements the Company enters into prior to Closing. The votes cast were as follows: |
Votes For |
|
Votes Against |
|
Abstentions |
|
15,302,080 |
|
778,039 |
|
390 |
|
7. |
The Company’s stockholders voted to approve the LanzaTech 2023 Long-Term Incentive Plan (the “Incentive Plan”), including the authorization of the initial share reserve, the aggregate number of shares issuable pursuant to incentive stock options (“ISOs”) within the meaning of section 422 of the Internal Revenue Code of 1986, as amended, and the class(es) of employees eligible for ISOs under the Incentive Plan. The votes cast were as follows: |
Votes For |
|
Votes Against |
|
Abstentions |
|
14,579,089 |
|
1,497,420 |
|
4,000 |
|
8. |
The Company’s stockholders voted to elect seven directors to serve on New LanzaTech’s board of directors. The votes cast were as follows: |
Nominee |
|
Votes For |
|
Votes Withheld |
|
Jennifer Holmgren (Class I) |
|
15,298,388 |
|
782,121 |
|
Nigel Gormly (Class I) |
|
15,298,588 |
|
781,921 |
|
Nimesh Patel (Class I) |
|
15,298,588 |
|
781,921 |
|
Barbara Byrne (Class II) |
|
15,298,488 |
|
782,021 |
|
Gary Rieschel (Class II) |
|
15,298,588 |
|
781,921 |
|
Jim Messina (Class III) |
|
15,298,588 |
|
781,921 |
|
Dorri McWhorter (Class III) |
|
15,298,488 |
|
782,021 |
|
The Closing is subject
to the satisfaction or waiver of a number of conditions set forth in the Merger Agreement. As of the date of the Special Meeting,
certain conditions are not yet satisfied. The Closing is expected to occur once all such conditions are satisfied or
waived. Following the consummation of the Business Combination, the common stock of New
LanzaTech is expected to trade on the Nasdaq Global Market and the warrants of New LanzaTech are expected to trade on the Nasdaq
Capital Market under the new symbols “LNZA” and “LNZAW,” respectively. Attached as Exhibit 99.1 to this
Current Report on Form 8-K is the press release jointly issued by the parties announcing the consummation of the Business
Combination.
Forward-Looking
Statements
This
Current Report on Form 8-K includes forward-looking statements regarding, among other things, the plans, strategies and
prospects, both business and financial, of AMCI and LanzaTech. These statements are based on the beliefs and assumptions of the
management of AMCI and LanzaTech, respectively. Although AMCI and LanzaTech believe that their respective plans, intentions and
expectations reflected in or suggested by these forward-looking statements are reasonable, neither AMCI nor LanzaTech can assure you
that either will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to
risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning possible
or assumed future actions, business strategies, events or results of operations, are forward-looking statements. These statements
may be preceded by, followed by or include the words “believes,” “estimates,” “expects,”
“projects,” “forecasts,” “may,” “will,” “should,” “seeks,”
“plans,” “scheduled,” “anticipates,” “intends” or similar expressions. The
forward-looking statements are based on projections prepared by, and are the responsibility of, AMCI’s management and
LanzaTech’s management, respectively. These forward-looking statements are not guarantees of future performance, conditions or
results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are
outside the control of AMCI and LanzaTech, that could cause actual results or outcomes to differ materially from those discussed in
the forward-looking statements. New risk factors that may affect actual results or outcomes emerge from time to time and it is not
possible to predict all such risk factors, nor can AMCI or LanzaTech assess the impact of all such risk factors on its business, or
the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any
forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these
statements, which speak only as of the date hereof. All forward-looking statements attributable to AMCI, LanzaTech or persons
acting on their behalf are expressly qualified in their entirety by the foregoing cautionary statements. AMCI and LanzaTech prior to
the Business Combination, and the combined company following the Business Combination, undertake no obligations to update or revise
publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by
law.
Item 9.01. |
Financial Statements and Exhibits. |
(d) Exhibits.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
AMCI ACQUISITION CORP. II |
Date: February 7, 2023 |
|
|
|
By: |
/s/ Nimesh Patel |
|
Name: |
Nimesh Patel |
|
Title: |
Chief Executive Officer |
AMCI Acquisition Corpora... (NASDAQ:AMCI)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
AMCI Acquisition Corpora... (NASDAQ:AMCI)
Historical Stock Chart
Von Dez 2023 bis Dez 2024